Simris Group AB (PUBL) (STO:SIMRIS.B)
Sweden · Delayed Price · Currency is SEK 0.1150
+0.0115 (11.11%)
Sep 22, 2026, 5:09 PM CET
Simris Group AB (PUBL) Market Cap
Simris Group AB (PUBL) has a market cap or net worth of 155.23 million as of September 22, 2026. Its market cap has increased by 77.36% in one year.
Market Cap
155.23M
Enterprise Value
147.24M
Revenue
1.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since April 22, 2016, Simris Group AB (PUBL)'s market cap has increased from 122.27M to 155.23M, an increase of 26.95%. That is a compound annual growth rate of 2.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 155.23M | 480.15% |
| Dec 30, 2025 | 26.76M | 0.88% |
| Dec 30, 2024 | 26.52M | -66.13% |
| Dec 29, 2023 | 78.32M | 72.71% |
| Dec 30, 2022 | 45.35M | -21.98% |
| Dec 30, 2021 | 58.12M | 3.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IRLAB Therapeutics AB | 256.68M |
| Isofol Medical AB | 237.16M |
| Xbrane Biopharma AB | 208.11M |
| Elicera Therapeutics AB | 185.86M |
| Abera Bioscience AB | 161.94M |
| Diamyd Medical AB | 156.53M |
| Initiator Pharma | 144.44M |
| Xintela AB | 138.66M |